NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
for Neuroblastoma
Drug: Irinotecan
Sites in Fort Worth, Dallas +11 more locations
Sponsor: New Approaches to Neuroblastoma Therapy Consortium
Sex: All·Age: 1 - 31
Code: NCT06450041·Phase 2·Recruiting·Listed Jun 2024